215 related articles for article (PubMed ID: 35645283)
1. Newborn Screening for X-Linked Adrenoleukodystrophy in Nebraska: Initial Experiences and Challenges.
Baker CV; Cady Keller A; Lutz R; Eveans K; Baumert K; DiPerna JC; Rizzo WB
Int J Neonatal Screen; 2022 Apr; 8(2):. PubMed ID: 35645283
[TBL] [Abstract][Full Text] [Related]
2. High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan.
Chen HA; Hsu RH; Chen PW; Lee NC; Chiu PC; Hwu WL; Chien YH
Mol Genet Metab Rep; 2022 Sep; 32():100902. PubMed ID: 36046390
[TBL] [Abstract][Full Text] [Related]
3. Therapy of X-linked adrenoleukodystrophy.
Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
[TBL] [Abstract][Full Text] [Related]
4. A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy.
Wiens K; Berry SA; Choi H; Gaviglio A; Gupta A; Hietala A; Kenney-Jung D; Lund T; Miller W; Pierpont EI; Raymond G; Winslow H; Zierhut HA; Orchard PJ
Am J Med Genet A; 2019 Jul; 179(7):1205-1213. PubMed ID: 31074578
[TBL] [Abstract][Full Text] [Related]
5. [X-linked adrenoleukodystrophy].
Aubourg P
Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
[TBL] [Abstract][Full Text] [Related]
6. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific newborn screening for X-linked adrenoleukodystrophy.
Albersen M; van der Beek SL; Dijkstra IME; Alders M; Barendsen RW; Bliek J; Boelen A; Ebberink MS; Ferdinandusse S; Goorden SMI; Heijboer AC; Jansen M; Jaspers YRJ; Metgod I; Salomons GS; Vaz FM; Verschoof-Puite RK; Visser WF; Dekkers E; Engelen M; Kemp S
J Inherit Metab Dis; 2023 Jan; 46(1):116-128. PubMed ID: 36256460
[TBL] [Abstract][Full Text] [Related]
9. Newborn Screening for X-Linked Adrenoleukodystrophy: Review of Data and Outcomes in Pennsylvania.
Priestley JRC; Adang LA; Drewes Williams S; Lichter-Konecki U; Menello C; Engelhardt NM; DiPerna JC; DiBoscio B; Ahrens-Nicklas RC; Edmondson AC; Reynoso Santos FJ; Ficicioglu C
Int J Neonatal Screen; 2022 Mar; 8(2):. PubMed ID: 35466195
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients.
Jang J; Kang HC; Kim HS; Kim JY; Huh YJ; Kim DS; Yoo JE; Lee JA; Lim B; Lee J; Yoon TM; Park IH; Hwang DY; Daley GQ; Kim DW
Ann Neurol; 2011 Sep; 70(3):402-9. PubMed ID: 21721033
[TBL] [Abstract][Full Text] [Related]
11. Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy.
Wu C; Iwamoto T; Igarashi J; Miyajima T; Hossain MA; Yanagisawa H; Akiyama K; Shintaku H; Eto Y
Mol Genet Metab Rep; 2017 Sep; 12():115-118. PubMed ID: 28725571
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring.
Bonaventura E; Alberti L; Lucchi S; Cappelletti L; Fazzone S; Cattaneo E; Bellini M; Izzo G; Parazzini C; Bosetti A; Di Profio E; Fiore G; Ferrario M; Mameli C; Sangiorgio A; Masnada S; Zuccotti GV; Veggiotti P; Spaccini L; Iascone M; Verduci E; Cereda C; Tonduti D;
Front Neurol; 2022; 13():1072256. PubMed ID: 36698902
[TBL] [Abstract][Full Text] [Related]
13. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations.
Kemp S; Pujol A; Waterham HR; van Geel BM; Boehm CD; Raymond GV; Cutting GR; Wanders RJ; Moser HW
Hum Mutat; 2001 Dec; 18(6):499-515. PubMed ID: 11748843
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort study.
Tran C; Patel J; Stacy H; Mamak EG; Faghfoury H; Raiman J; Clarke JTR; Blaser S; Mercimek-Mahmutoglu S
Eur J Paediatr Neurol; 2017 Jul; 21(4):600-609. PubMed ID: 28274546
[TBL] [Abstract][Full Text] [Related]
15. Two Single Nucleotide Deletions in the
Dohr KA; Tokic S; Gastager-Ehgartner M; Stojakovic T; Dumic M; Plecko B; Dumic KK
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983033
[TBL] [Abstract][Full Text] [Related]
16. Retrospective evaluation of patients with X-linked adrenoleukodystrophy with a wide range of clinical presentations: a single center experience.
Olgac A; Kasapkara ÇS; Derinkuyu B; Yüksel D; Çetinkaya S; Aksoy A; Ceylaner S; Güleray N; Yeşilipek A; Aydın Hİ; Orgun LT; Kılıç M
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1169-1179. PubMed ID: 34162029
[TBL] [Abstract][Full Text] [Related]
17. Targeted metabolomics revealed changes in phospholipids during the development of neuroinflammation in Abcd1
Kettwig M; Klemp H; Nessler S; Streit F; Krätzner R; Rosewich H; Gärtner J
J Inherit Metab Dis; 2021 Sep; 44(5):1174-1185. PubMed ID: 33855724
[TBL] [Abstract][Full Text] [Related]
18. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds.
van Geel BM; Assies J; Weverling GJ; Barth PG
Neurology; 1994 Dec; 44(12):2343-6. PubMed ID: 7991123
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.
Theda C; Gibbons K; Defor TE; Donohue PK; Golden WC; Kline AD; Gulamali-Majid F; Panny SR; Hubbard WC; Jones RO; Liu AK; Moser AB; Raymond GV
Mol Genet Metab; 2014 Jan; 111(1):55-7. PubMed ID: 24268529
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
